Trials / Completed
CompletedNCT01675622
Immediate-Release Oxycodone Capsules Study in Cancer Pain
A Comparative Study of Immediate-Release Oxycodone Capsules Versus Immediate-Release Morphine Tablets for the Treatment of Chinese Patients With Cancer Pain.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 242 (actual)
- Sponsor
- Mundipharma (China) Pharmaceutical Co. Ltd · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The efficacy of dose titration of OxyNorm™(Oxycodone) immediate-release capsules versus morphine immediate-release tablets in the treatment of cancer pain.
Detailed description
To compare the efficacy of dose titration of OxyNorm™(Oxycodone) immediate-release capsules versus morphine immediate-release tablets in the treatment of cancer pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxycodone | dosage: 5mg, l0mg and 20mg dosage form: capsule frequency: every 6h, duration: 5-8 days |
| DRUG | Morphine | Morphine tablets 10mg and 20mg, oral every 4-6 hours |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-06-01
- Completion
- 2012-07-01
- First posted
- 2012-08-30
- Last updated
- 2018-05-21
- Results posted
- 2018-05-21
Source: ClinicalTrials.gov record NCT01675622. Inclusion in this directory is not an endorsement.